Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun 27;8(6):e17712.
doi: 10.5812/jjm.8(5)2015.17712. eCollection 2015 Jun.

Pseudomonas aeruginosa PAO-1 Lipopolysaccharide-Diphtheria Toxoid Conjugate Vaccine: Preparation, Characterization and Immunogenicity

Faezeh Najafzadeh  1 , Reza Shapouri  2 , Mehdi Rahnema  3 , Shadi Rokhsartalab Azar  4 , Anvarsadat Kianmehr  5
Affiliations

Pseudomonas aeruginosa PAO-1 Lipopolysaccharide-Diphtheria Toxoid Conjugate Vaccine: Preparation, Characterization and Immunogenicity

Faezeh Najafzadeh et al. Jundishapur J Microbiol. .

Abstract

Background: Treatment of Pseudomonas aeruginosa PAO-1 infections through immunological means has been proved to be efficient and protective.

Objectives: The purpose of this study was to produce a conjugate vaccine composed of detoxified lipopolysaccharide (D-LPS) P. aeruginosa and diphtheria toxoid (DT).

Materials and methods: Firstly, LPS was purified and characterized from P. aeruginosa PAO1 and then detoxified. D-LPS was covalently coupled to DT as a carrier protein via amidation method with adipic acid dihydrazide (ADH) as a spacer molecule and 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide (EDAC) as a linker. The molar ratio of LPS to DT in the prepared conjugate was 3:1. The immunogenicity of D-LPS-DT conjugate vaccine in mice model was evaluated as well.

Results: The conjugate was devoid of endotoxin activity and 0.125 U/mL of D-LPS was acceptable for immunization. D-LPS-DT conjugate was nonpyrogenic for rabbits and nontoxic for mice. Mice immunization with D-LPS-DT conjugate vaccine elicited the fourfold higher IgG antibody compared to D-LPS. Anti-LPS IgG antibody was predominantly IgG1 subclass and then IgG3, IgG2a and IgG2b, respectively.

Conclusions: Vaccine based on the conjugation of P. aeruginosa PAO-1 LPS with DT increased anti-LPS antibodies and had a significant potential to protect against Pseudomonas infections.

Keywords: Diphtheria Toxoid; Lipopolysaccharides; Pseudomonas aeruginosa PAO-1; Vaccines, Conjugate.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Silver Nitrate-Stained SDS-PAGE of Extracted Pseudomonas aeruginosa LPS
Lane 1: 10 μg of LPS, lane 2: 5 μg of LPS.
Figure 2.
Figure 2.. Gel Filtration Profile of D-LPS-DT Conjugate Through a CL-2B Sepharose Column
Figure 3.
Figure 3.. Induction of Anti-LPS Antibodies in BALB/C Mice for Days 28 (A) and 42 (B)
See this image and copyright information in PMC

References

    1. Siegel RE. Emerging gram-negative antibiotic resistance: daunting challenges, declining sensitivities, and dire consequences. Respir Care. 2008;53(4):471–9. - PubMed
    1. Taheri ZM, Shahbazi N, Khoddami M. Genetic Diversity of pseudomonas aeruginosa Strains isolated from Hospitalized patients. Tanaffos. 2008;7(1):32–9.
    1. Al-Zeer M, Masoud H. LPS-based conjugate vaccines composed of O-polysaccharide from Pseudomonas aeruginosa IATS 6 and 11 bound to a carrier protein. World J Microbiol Biotechnol . 2007;23(11):1541–9.
    1. Donta ST, Peduzzi P, Cross AS, Sadoff J, Haakenson C, Cryz SJ, et al. Immunoprophylaxis against Klebsiella and Pseudomonas aeruginosa Infections. J Infect Dis. 1996;174(3):537–43. - PubMed
    1. Cryz SJJ, Lang AB, Sadoff JC, Germanier R, Furer E. Vaccine potential of Pseudomonas aeruginosa O-polysaccharide-toxin A conjugates. Infect Immun. 1987;55(7):1547–51. - PMC - PubMed

LinkOut - more resources